Advertisement
Screener

HCW Biologics Inc. (HCWB) Form D

HCW Biologics Inc. Form D Notices of Exempt Offering of Securities

Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.

  • 2024-02-27: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2024-02-20; Total offering amount $2,500,005.
  • 2020-10-19: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2020-09-30; Total offering amount $16,000,000.
FiledFederal exemptionTypes of securities offeredDate of first saleTotal offering amountTotal amount soldTotal remaining to be soldInvestors who have already invested
2024-02-27Rule 506(b)Equity2024-02-20$2,500,005$2,500,005$06
2020-10-19Rule 506(b)Equity2020-09-30$16,000,000$6,168,320$9,831,6809

Similar stocks

Stock NameCountryMarket CapPE Ratio
REVELATION BIOSCIENCES, INC. (REVB)United States$0.004B
Onconetix, Inc. (ONCO)United States$0.004B
Aptevo Therapeutics Inc. (APVO)United States$0.003B
60 DEGREES PHARMACEUTICALS, INC. (SXTP)United States$0.004B-0.59
Sunshine Biopharma Inc. (SBFM)$0.003B
Lakewood-Amedex Biotherapeutics Inc. (LABT)United States$0.004B
Cadrenal Therapeutics, Inc. (CVKD)United States$0.004B-0.90
Alaunos Therapeutics, Inc. (TCRT)United States$0.003B-1.44
Genprex, Inc. (GNPX)United States$0.003B-0.02
Silo Pharma, Inc. (SILO)United States$0.003B-1.57